FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis (vol 28, pg 285, 2015)

被引：44
|
作者：
Dahan, Rony
Sega, Emanuela
Engelhardt, John
Selby, Mark
Korman, Alan J.
Ravetch, Jeffrey V.
机构：
来源：
CANCER CELL | 2015年 / 28卷 / 04期
关键词：
D O I：
10.1016/j.ccell.2015.09.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [1] FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
    Dahan, Rony
    Sega, Emanuela
    Engelhardt, John
    Selby, Mark
    Korman, Alan J.
    Ravetch, Jeffrey V.
    CANCER CELL, 2015, 28 (03) : 285 - 295
  • [2] Aptamers Targeting the PD-1/PD-L1 Axis: A Perspective
    Bertrand, Philippe
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (16) : 10878 - 10888
  • [3] Targeting the PD-1/PD-L1 Axis in Human Vitiligo
    Willemsen, Marcella
    Melief, Cornelis J. M.
    Bekkenk, Marcel W.
    Luiten, Rosalie M.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [4] Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
    Chen, Miaomiao
    Zhou, Yuli
    Bao, Kaicheng
    Chen, Siyu
    Song, Guoqing
    Wang, Siliang
    BIODRUGS, 2025,
  • [5] Design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-L1 and inhibitors of PD-1/PD-L1 interaction
    Zhang, Feng
    Yu, Qimeng
    Wu, Caiyun
    Sun, Shishi
    Wang, Yu
    Wang, Rui
    Chen, Zejie
    Zhang, Hua
    Xiong, Xuqiong
    Awadasseid, Annoor
    Rao, Guowu
    Zhao, Xiaoyin
    Zhang, Wen
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 111
  • [6] A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
    Albu, Diana I.
    Wolf, Benjamin J.
    Qin, Yan
    Wang, Xianzhe
    Ulumben, Amy Daniel
    Su, Mei
    Li, Vivian
    Ding, Eirene
    Gonzalo, Jose Angel
    Kong, Jason
    Jadhav, Ruturaj
    Kuklin, Nelly
    Visintin, Alberto
    Gong, Bing
    Schuetz, Thomas J.
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [7] Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
    Topalian, Suzanne L.
    Drake, Charles G.
    Pardoll, Drew M.
    CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (02) : 207 - 212
  • [8] PD-1 and PD-L1 antibodies for melanoma
    Tsai, Katy K.
    Zarzoso, Ines
    Daud, Adil I.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3111 - 3116
  • [9] Prospects for Targeting PD-1 and PD-L1 in Various Tumor Types
    Kim, Joseph W.
    Eder, Joseph Paul
    ONCOLOGY-NEW YORK, 2014, 28 : 15 - 28
  • [10] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Annika De Sousa Linhares
    Claire Battin
    Sabrina Jutz
    Judith Leitner
    Christine Hafner
    Joshua Tobias
    Ursula Wiedermann
    Michael Kundi
    Gerhard J. Zlabinger
    Katharina Grabmeier-Pfistershammer
    Peter Steinberger
    Scientific Reports, 9
12345